Inclusion Body Myositis
Boundaries That May Define Transition to Treatment Refractoriness
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received July 5, 2022
- Accepted in final form September 19, 2022
- First Published October 4, 2022.
Article Versions
- Previous version (October 4, 2022 - 13:06).
- You are viewing the most recent version of this article.
Author Disclosures
- Steven A. Greenberg, MD
- Steven A. Greenberg, MD
None
NONE
None
NONE
KLRG1 depletion therapy (US20190194333A1)
NONE
NONE
Abcuro, Inc.
NONE
NONE
NONE
NONE
NONE
Harvard Medical School Blavatnik Translational Center
None
NONE
KLRG1 targeting, Abcuro Inc to Brigham and Women's Hospital
Myositis diagnostics, Medimmune to Brigham and Women's <br>Hospital
NONE
NONE
NONE
- Correspondence
Dr. Greenberg sagreenberg{at}bwh.harvard.edu
Article usage
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Jeffrey Allen and Dr. Nicholas Purcell